Synchronization of metformin with sitagliptin on the expression of` miRNA21, 223 in insulin resistant human adipocyte tissue and serum
Phase 3
Recruiting
- Conditions
- Insulin resistance.
- Registration Number
- IRCT20180408039225N1
- Lead Sponsor
- Yazd University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Everybody as diabetic for the first time and new case was selected, and if have HOMA index more than 1.5 are case group and less than 1.5 are control group.
Exclusion Criteria
Everybody as diabetic or used to diabetic drugs or insulin and everybody had hormone therapy or with endocrine disorders, persons with renal disorders and cancer or malignant tumors and had chemotherapy are deleted from survey.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method MiRNA changes. Timepoint: First -End. Method of measurement: RT_PCR method.
- Secondary Outcome Measures
Name Time Method